HCPLive

JANUARY 8, 2024

Serum-COMP was linked to an increased risk of both cardiovascular disease and coronary artery disease.

Cardiovascular Disease 69

Cardiovascular Disease Coronary Artery Disease 69

Journal of the American Heart Association

JANUARY 12, 2024

ABSTRACT: Albuminuria, an established biomarker of the progression of chronic kidney disease, is also recognized as a biomarker for the risk of cardiovascular disease. Elevated urinary albumin excretion indicates kidney damage and systemic vascular disease, including myocardial capillary disease and arterial stiffness.

Cardiovascular Disease 71

Cardiovascular Disease Risk Factors Coronary Artery Disease Kidney Disease 71

Cardiovascular Diabetology

AUGUST 27, 2024

Objective We aimed to summarize the association between gestational diabetes mellitus (GDM) and its intergenerational cardiovascular diseases (CVDs) impacts in both mothers and offspring post-delivery in existing literature.

Cardiovascular Disease 85

Cardiovascular Disease Diabetes Coronary Artery Disease Cerebrovascular Disease 85

Science Daily - Stroke

JUNE 12, 2023

Around the world, most people are regularly exposed to low or moderate levels of lead, cadmium and arsenic in the environment, increasing risk of coronary artery disease, stroke and peripheral artery disease, according to a new statement.

Peripheral Arterial Disease 80

Peripheral Arterial Disease Coronary Artery Disease Cardiovascular Disease Stroke 80

Science Daily - Heart Disease

FEBRUARY 7, 2024

However, researchers lack efficient ways to explore how these genetic variants are molecularly connected to cardiovascular disease, limiting efforts to develop therapeutics.

Research 111

Research Coronary Artery Disease Heart Disease Heart Attack 111

Circulation

NOVEMBER 11, 2024

Recent statistics indicate that a high CAVI score has the potential to predict future cardiovascular disease (CVD) occurrences. Out of these, 162 patients had chronic coronary artery disease (CAD), while the remaining 62 patients were free of CAD. CAVI in the CVD events group (9.77±1.06) 0.72) group (p=0.009).

Coronary Artery Disease 40

Coronary Artery Disease Cardiovascular Disease Stenosis Blood Pressure 40

Cardiometabolic Health Congress

JANUARY 16, 2025

Atherosclerosis (ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. Key strategies include: Polygenic Risk Scores: Identifying Risk Early PRS helps identify young adults at high lifetime risk for coronary artery disease (CAD).

Atherosclerosis 59

Atherosclerosis Risk Factors Coronary Artery Disease Cardiovascular Disease 59

DAIC

DECEMBER 5, 2024

Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. Cleerly’s pioneering approach to advanced cardiovascular imaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

Cardiovascular Diabetology

FEBRUARY 23, 2024

Intensive glycemic control reduced coronary artery disease (CAD) events among the Action to Control Cardiovascular Disease Risk in Diabetes (ACCORD) participants with the haptoglobin (Hp) 2-2 phenotype only.

Coronary Artery Disease 52

Coronary Artery Disease Diabetes Cardiovascular Disease Research 52

Dr. Paddy Barrett

APRIL 5, 2024

A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.

Heart Disease 117

Heart Disease Coronary Artery Disease Heart Attack Heart attacks 117

DAIC

MARCH 31, 2025

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart Attack 52

Frontiers in Cardiovascular Medicine

APRIL 29, 2024

However, the influence of ICP on cardiovascular disease (CVD), including hypertension (HTN) and coronary artery disease (CAD), has not been thoroughly investigated.MethodsThis study explores the causal relationship between ICP and CVD (HTN, CAD) using Mendelian Randomization (MR). 4% of pregnancies.

Cardiovascular Disease 52

Cardiovascular Disease Genetic predisposition Coronary Artery Disease Hypertension 52

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

Dr. Paddy Barrett

APRIL 26, 2024

Coronary artery disease is caused by the retention of a cholesterol particle in the artery wall. Insulin resistance and diabetes may not ‘ cause ’ coronary artery disease, but they are huge accelerants. If delaying the onset of major chronic disease is your goal. Timing Matters.

Heart Disease 104

Heart Disease Coronary Artery Disease Diabetes Genetic predisposition 104

Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Background and aims In the non-metropolitan region of Brandenburg (Germany), which is characterized by high rates of cardiovascular diseases and underserved medical care, there is a lack of awareness regarding lipoprotein(a) [Lp(a)] as a risk factor. 3.95, p  = 0.003). vs. 45.8%; 17.6% vs. 13.9%, p  = 0.001).

Risk Factors 59

Risk Factors Cardiovascular Disease Peripheral Arterial Disease Coronary Artery Disease 59

European Journal of Heart Failure

MARCH 10, 2025

Abstract Aims Clonal haematopoiesis (CH) is recognized as a significant risk factor for various non-haematologic conditions, including cardiovascular diseases. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure.

Heart Failure 40

Heart Failure Outcomes Coronary Artery Disease Risk Factors 40

DAIC

JANUARY 17, 2024

At present, machine learning, deep learning, and other AI technologies have been tried to be applied to intelligent diagnostic and decision making, image interpretation, accurate classification, and prognostication of cardiovascular diseases, which has led to broad application prospects and innovation potential.

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

DAIC

JULY 19, 2024

The study evaluated the ability of the Fat Attenuation Index (FAI) Score on routine CCTA to predict cardiovascular outcomes in different socioeconomic classes, ethnicity groups, and in the presence or absence of obstructive coronary artery disease (CAD).

Coronary Artery Disease 111

Coronary Artery Disease Academic Plaque Research 111

MIBHS

JANUARY 15, 2025

Smoking is a well-known health hazard, contributing to a wide array of diseases and conditions. Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovascular diseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Blood Clot Blood Pressure Plaque 52

The New England Journal of Medicine

MAY 28, 2024

Such exceptional persons across diverse communities are playing an important role in the genesis of medicines for common cardiovascular diseases. The discovery of.

Coronary Artery Disease 40

Coronary Artery Disease Cardiovascular Disease 40

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Methods This narrative review examines the contemporary literature assessing intermediate- and long-term event rates in patients with established CV disease treated with statins.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Cardiovascular Disease Coronary Artery Disease Cerebrovascular Disease 64

Journal of the American Heart Association

MARCH 4, 2025

In congenital heart diseases, SDoHs can affect major outcomes, as well. In conclusion, SDoHs significantly impact cardiovascular morbidity and death and specific outcomes of patients with cardiovascular disease.

Cardiovascular Disease 40

Cardiovascular Disease Peripheral Arterial Disease Congenital Heart Disease Coronary Artery Disease 40

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. The DynamX bioadaptor has a novel design and mechanism of action designed to return the diseased vessel to a more normal condition, through three distinct phases.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

MAY 31, 2024

Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally.

Peripheral Arterial Disease 104

Peripheral Arterial Disease Innovation Coronary Artery Disease Cardiovascular Interventions 104

DAIC

JANUARY 25, 2024

Getty Images milla1cf Thu, 01/25/2024 - 20:44 January 25, 2024 — Agepha Pharma , a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment ( LODOCO – colchicine, 0.5 For more information: [link] Related content: U.S.

Heart Attack 110

Heart Attack Heart attacks Technology Cardiovascular Disease 110

Dr. Paddy Barrett

DECEMBER 26, 2023

ApoB The relationship of serum ApoB levels and cardiovascular risk over your lifetime is clear. The greater the cumulative exposure the higher the likelihood of cardiovascular disease. The lower your cumulative ApoB over your lifetime the lower your cardiovascular risk. Subscribe now The inverse then holds true.

Coronary Artery Disease 102

Coronary Artery Disease Plaque Heart Attack Heart attacks 102

DAIC

JULY 25, 2024

“We are encouraged by the implementation of our AI cardiac solution at esteemed healthcare systems, along with the continued validation through real-world studies of its potential to promote early detection and preventive care of cardiovascular disease,” said Erez Meltzer, Nanox Chief Executive Officer and Acting Chairman. “We

Innovation 105

Innovation Coronary Artery Disease Hospital Cardiovascular Disease 105

Cardiovascular Diabetology

APRIL 1, 2024

Atherogenic index of plasma (AIP) represents a novel marker in the current era of cardiovascular diseases. In this meta-analysis, we aimed to evaluate the association of AIP with cardiovascular prognosis in pa.

Coronary Artery Disease 52

Coronary Artery Disease Cardiovascular Disease Outcomes 52

Science Daily - Heart Disease

APRIL 30, 2024

Atherosclerosis is characterized by a narrowing of arterial walls and can increase risk of coronary artery disease, stroke, peripheral artery disease, or kidney disorders.

Atherosclerosis 58

Atherosclerosis Cancer Peripheral Arterial Disease Coronary Artery Disease 58

Coronary Artery Disease Journal

MAY 26, 2024

Background Patients with cardiovascular disease (CVD) and risk factors have increased rates of adverse events and mortality after hospitalization for coronavirus disease 2019 (COVID-19). 2.21) were also significantly higher for COVID-19 hospitalizations with coronary artery disease.

COVID-19 40

COVID-19 Cardiovascular Disease Hospital Coronary Artery Disease 40

American College of Cardiology

FEBRUARY 1, 2025

In a retrospective study of older patients (≥65 years) with cardiovascular disease who were admitted to a cardiology service, the prevalence of polypharmacy (five or more medications) was 95% and 69% for hyper-polypharmacy (≥10 medications), far exceeding that observed in the general population; 77.5% Circulation. 2021;374:n1493.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

Journal of Cardiovascular Pharmacology

JANUARY 8, 2024

Traditional Chinese herbal medicine (CHM) has been extensively used in cardiovascular disease in modern clinical practice, alone or in combination with conventional treatment. CHM, with or without conventional treatment, showed a consistent beneficial effect in various cardiovascular diseases.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease Angina Heart Failure 40

Journal of the American Heart Association

DECEMBER 29, 2023

BackgroundDespite the health effects of basal metabolic rate (BMR), the causal effect of BMR on cardiovascular diseases (CVDs) remains undetermined. Genetically predicted BMR may not be causally associated with coronary artery disease and ischemic stroke risk. 1.92];P<0.001).

Cardiovascular Disease 45

Cardiovascular Disease Atrial Fibrillation Aneurysm Coronary Artery Disease 45

Frontiers in Cardiovascular Medicine

JANUARY 21, 2024

Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL).

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Coronary Artery Disease Cerebrovascular Disease 45

DAIC

JUNE 4, 2024

Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. fold higher risk for cardiac mortality and 5.5-fold

Technology 116

Technology Heart Attack Heart attacks Coronary Artery Disease 116

DAIC

APRIL 3, 2024

Cardiovascular Update for the Clinician: A Symposium by Valentin Fuster” will offer the latest advances in the treatment of cardiovascular disease and ways to integrate them into daily practice. 24 Education Sessions Symposiums at ACC The “Symposiums at ACC.24” Too Many Choices?

Education 105

Education Preserved Ejection Fraction Coronary Artery Disease Cardio Oncology 105

Frontiers in Cardiovascular Medicine

MARCH 4, 2024

Atherosclerotic coronary artery disease (CAD) is the causal pathological process driving most major adverse cardiovascular events (MACE) worldwide. For many disease areas, nearly a half of drugs are approved by the U.S. Food & Drug Administration based on beneficial effects on surrogate endpoints.

Plaque 59

Plaque Coronary Artery Disease Blood Pressure Cardiovascular Disease 59